Evidence map›Paper›PMID 42130935›Full record

ArticleEuropean journal of case reports in internal medicine2026

Coexisting Waldenström Macroglobulinaemia and Alveolar Echinococcosis Presenting with Chylothorax that Resolved on Treatment: A Diagnostic and Therapeutic Challenge.

François Perramond, Serge Bugnon, Jérôme Voegeli, Annalisa Berzigotti

Abstract read
In one paragraph

Article in European journal of case reports in internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

François PerramondDepartment of Internal Medicine, Hôpital de Saint-Imier, Saint-Imier, Switzerland.
Serge BugnonDepartment of Internal Medicine, Hôpital de Saint-Imier, Saint-Imier, Switzerland.
Jérôme VoegeliDepartment of Haematology, Centre Médico-Chirurgical Volta, La Chaux-de-Fonds, Switzerland.
Annalisa BerzigottiDepartment of Hepatology, Inselspital, Hôpital Universitaire de Berne, Berne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Waldenström macroglobulinaemia is a lymphoplasmacytic lymphoma producing monoclonal immunoglobulin M (IgM), and both the disease and its treatment can cause immunosuppression. Alveolar echinococcosis is a parasitic infection that primarily involves the liver but may present with extrahepatic manifestations. Case description: We report the case of a patient who presented with chylothorax and non-specific hepatic lesions and was then diagnosed with Waldenström macroglobulinaemia. In addition to this diagnosis, alveolar echinococcosis was subsequently confirmed by liver biopsy and serology. Discussion: Diagnostic interpretation was challenging, as these features may occur in both conditions. A multidisciplinary approach was needed to establish the treatment plan due to overlapping symptomatology and the risk of treatment-related immunosuppression. Conclusion: This case highlights the importance of considering a broad differential diagnosis for a chylothorax and hepatic lesions in an oncological context and illustrates the therapeutic challenges of managing an indolent haematologic malignancy in the context of a chronic parasitic infection. LEARNING POINTS: Chylothorax has a large differential diagnosis and is often difficult to treat.Echinococcosis can clinically and radiologically mimic malignancy.The investigation and management of a patient with both conditions are challenging.

Indexed as

alveolar echinococcosischylothoraxWaldenström macroglobulinaemiazanubrutinib

Identifiers

PMID42130935
PMCPMC13166984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.